The prospects of hepatic drug delivery and gene therapy.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Expert Opinion on Investigational Drugs

• Publication date

  1998-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1517/13543784.7.11.1795PMID 15991930
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Changes in receptor-mediated endocytosis in liver sinusoidal cells after partial hepatectomy in the rat.

  2008cited by this paper
• macrophages: Role of membrane phosphatidylserine

  2005cited by this paper
• Pre-clinical trials using hepatic gene delivery.

  1998cited by this paper
• Polyethylenimine but Not Cationic Lipids Promotes Transgene Delivery to the Nucleus in Mammalian Cells*

  1998cited by this paper
• Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig

  1998cited by this paper
• Microspheres as a drug delivery system in cancer therapy

  1998cited by this paper
• Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity

  1998cited by this paper
• Increased liver uptake of liposomes and improved targeting efficacy by labeling with asialofetuin in rodents

  1998cited by this paper
• Stabilization of cationic liposome‐plasmid DNA complexes by polyamines and poly(ethylene glycol)‐phospholipid conjugates for efficient in vivo gene delivery

  1997cited by this paper
• A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis

  1997cited by this paper
• Inhibition of hepatitis B virus by retroviral vectors expressing antisense RNA

  1997cited by this paper
• Cationic Lipid-Based Gene Delivery Systems: Pharmaceutical Perspectives

  1997cited by this paper
• Improved DNA: liposome complexes for increased systemic delivery and gene expression

  1997cited by this paper
• Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors.

  1997cited by this paper
• Liver-Directed Gene Transfer in Non-Human Primates

  1997cited by this paper
• Gene Transfer and Therapy with Adenoviral Vector in Rats with Diethylnitrosamine-Induced Hepatocellular Carcinoma

  1997cited by this paper
• Transient immunosuppression with FK506 permits long‐term expression of therapeutic genes introduced into the liver using recombinant adenoviruses in the rat

  1997cited by this paper
• New therapies for chronic hepatitis B

  1997cited by this paper
• The promise and reality of cancer gene therapy.

  1997cited by this paper
• Selective hepatic drug delivery: From basic concept to clinical practice

  1997cited by this paper
• Selective hepatic drug delivery: From basic concept to clinical practice

  1997cited by this paper
• Formulation of liposomes with a soybean-derived sterylglucoside mixture and cholesterol for liver targeting.

  1997cited by this paper
• Systemic and hepatic hemodynamic changes in acute liver injury.

  1997cited by this paper
• Adenovirus gene therapy for hypercholesterolemia, thrombosis and restenosis.

  1997cited by this paper
• Therapeutic levels of functional human factor X in rats after retroviral-mediated hepatic gene therapy.

  1997cited by this paper
• Design and preparation of a multimeric self-cleaving hammerhead ribozyme.

  1997cited by this paper
• Non‐surgical treatment of hepatocellular carcinoma

  1997cited by this paper
• Phase I study of immunotherapy of hepatic metastases of colorectal carcinoma by direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7

  1997cited by this paper
• Influence of drug release characteristics on the therapeutic activity of liposomal mitoxantrone.

  1997cited by this paper
• In vivo gene transfer via intravenous administration of cationic lipid–protamine–DNA (LPD) complexes

  1997cited by this paper
• Hepatic drug delivery and gene therapy

  1997cited by this paper
• Overcoming the inhibitory effect of serum on lipofection by increasing the charge ratio of cationic liposome to DNA

  1997cited by this paper
• Receptor mediated delivery of daunomycin using immunoliposomes: pharmacokinetics and tissue distribution in the rat.

  1997cited by this paper
• Targeting naproxen coupled to human serum albumin to nonparenchymal cells reduces endotoxin‐induced mortality in rats with biliary cirrhosis

  1997cited by this paper
• Long-term expression of the human alpha1-antitrypsin gene in mice employing anionic and cationic liposome vector.

  1997cited by this paper
• Human recombinant apolipoprotein E-enriched liposomes can mimic low-density lipoproteins as carriers for the site-specific delivery of antitumor agents.

  1997cited by this paper
• Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors

  1997cited by this paper
• Different intrahepatic distribution of phosphatidylglycerol and phosphatidylserine liposomes in the rat

  1997cited by this paper
• In vivo gene delivery to the liver using reconstituted chylomicron remnants as a novel nonviral vector.

  1997cited by this paper
• Use of SV40-based vectors to transduce foreign genes to normal human peripheral blood mononuclear cells

  1997cited by this paper
• Gene therapy for chronic viral hepatitis: Ribozymes, antisense oligonucleotides, and dominant negative mutants

  1997cited by this paper
• Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus.

  1997cited by this paper
• Intracellular application of hairpin ribozyme genes against hepatitis B virus

  1997cited by this paper
• In vivo gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene.

  1997cited by this paper
• Viral Vector-Mediated Gene Therapy for Hemophilia B

  1997cited by this paper
• Biophysical characterization of cationic lipid: DNA complexes.

  1997cited by this paper
• Massive targeting of liposomes, surface-modified with anionized albumins, to hepatic endothelial cells.

  1997cited by this paper
• Nucleic acid‐based antiviral and gene therapy of chronic hepatitis B infection

  1997cited by this paper
• Long-term expression of the human alpha1-antitrypsin gene in mice employing anionic and cationic liposome vectors.

  1996cited by this paper
• Development and Pharmacokinetics of Galactosylated Poly-L-Glutamic Acid as a Biodegradable Carrier for Liver-Specific Drug Delivery

  1996cited by this paper
• Somatic gene therapy for phenylketonuria and other hepatic deficiencies

  1996cited by this paper
• Complete correction of hyperbilirubinemia in the Gunn rat model of Crigler-Najjar syndrome type I following transient in vivo adenovirus-mediated expression of human bilirubin UDP-glucuronosyltransferase.

  1996cited by this paper
• Selective Killing of AFP-Positive Hepatocellular Carcinoma Cells by Adeno-Associated Virus Transfer of the Herpes Simplex Virus Thymidine Kinase Gene

  1996cited by this paper
• Portal Branch Occlusion Safely Facilitates In Vivo Retroviral Vector Transduction of Rat Liver

  1996cited by this paper
• Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis

  1996cited by this paper
• SV40 as an effective gene transfer vector in vivo.

  1996cited by this paper
• Elimination of hepatitis C virus RNA in infected human hepatocytes by adenovirus-mediated expression of ribozymes

  1996cited by this paper
• Intracellular cleavage of hepatitis C virus RNA and inhibition of viral protein translation by hammerhead ribozymes.

  1996cited by this paper
• Human alpha 1-antitrypsin gene transfer to in vivo mouse hepatocytes.

  1996cited by this paper
• A Hitchhiker's guide to antisense and nonantisense biochemical pathways

  1996cited by this paper
• Microtubular Disruption Prolongs the Expression of Human Bilirubin-uridinediphosphoglucuronate-glucuronosyltransferase-1 Gene Transferred into Gunn Rat Livers (*)

  1996cited by this paper
• Liver-Directed Gene Therapy: A Retroviral Vector with a Complete LTR and the ApoE Enhancer-α 1-Antitrypsin Promoter Dramatically Increases Expression of Human α 1-Antitrypsin In Vivo

  1996cited by this paper
• Formulation of Polyiodinated Triglyceride Analogues in a Chylomicron Remnant-Like Liver-Selective Delivery Vehicle

  1996cited by this paper
• Targeting hepatitis B therapy to the liver. Clinical pharmacokinetic considerations.

  1996cited by this paper
• Liver-directed gene transfer and application to therapy

  1996cited by this paper
• Receptor‐mediated delivery of hepatitis B virus DNA and antisense oligodeoxynucleotides to avian liver cells

  1996cited by this paper
• Potentiation of cationic liposome-mediated gene delivery by polycations.

  1996cited by this paper
• Transient immune blockade prevents formation of neutralizing antibody to recombinant adenovirus and allows repeated gene transfer to mouse liver.

  1996cited by this paper
• A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA.

  1996cited by this paper
• SV40 mediates stable gene transfer in vivo.

  1996cited by this paper
• In pursuit of antisense.

  1996cited by this paper
• Modification of liposomes for liver targeting.

  1996cited by this paper
• Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy

  1996cited by this paper
• Long Term Correction of Bilirubin-UDP-glucuronosyltransferase Deficiency in Gunn Rats by Administration of a Recombinant Adenovirus during the Neonatal Period*

  1996cited by this paper
• Safety and feasibility of liver-directed ex vivo gene therapy for homozygous familial hypercholesterolemia.

  1996cited by this paper
• Targeting Hepatitis B Therapy to the Liver

  1996cited by this paper
• Human α1-Antitrypsin Gene Transfer to In Vivo Mouse Hepatocytes

  1996cited by this paper
• Inhibition of hepatitis B virus replication by targeted pretreatment of complexed antisense DNA in vitro

  1996cited by this paper
• Liver-directed gene therapy: a retroviral vector with a complete LTR and the ApoE enhancer-alpha 1-antitrypsin promoter dramatically increases expression of human alpha 1-antitrypsin in vivo.

  1996cited by this paper
• Liposome-encapsulated DNA-mediated gene transfer and synthesis of human factor IX in mice.

  1995cited by this paper
• Expression of the hepatitis C virus genome in rat liver after cationic liposome‐mediated in vivo gene transfer

  1995cited by this paper
• Lipospermine-Based Gene Transfer into the Newborn Mouse Brain Is Optimized by a Low Lipospermine/DNA Charge Ratio

  1995cited by this paper
• Targeting of Drugs to the Liver

  1995cited by this paper
• New synthetic amphiphilic polymers for steric protection of liposomes in vivo.

  1995cited by this paper
• A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia

  1995cited by this paper
• Prospects of Therapy of Liver Diseases with Foreign Genes

  1995cited by this paper
• Selective liver targeting of antivirals by recombinant chylomicrons — a new therapeutic approach to hepatitis B

  1995cited by this paper
• Physicochemical and pharmacokinetic characteristics of plasmid DNA/cationic liposome complexes.

  1995cited by this paper
• Clinical implications of gene therapy for alpha 1-antitrypsin deficiency.

  1995cited by this paper
• Efficient gene delivery with neutral complexes of lipospermine and thiol-reactive phospholipids.

  1995cited by this paper
• Vitamin E therapy of acute CCl4‐induced hepatic injury in mice is associated with inhibition of nuclear factor kappa B binding

  1995cited by this paper
• In vivo gene therapy for hyperlipidemia: phenotypic correction in Watanabe rabbits by hepatic delivery of the rabbit LDL receptor gene.

  1995cited by this paper
• Use of dominant negative mutants of the hepadnaviral core protein as antiviral agents

  1995cited by this paper
• Site specific microencapsulated drug targeting strategies- liver and gastro-intestinal tract targeting

  1995cited by this paper
• The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus.

  1995cited by this paper
• Antisense oligonucleotides are effective inhibitors of hepatitis B virus replication in vitro.

  1995cited by this paper
• In Vivo Adenovirus-Mediated Gene Transfer of the Escherichia coli Cytosine Deaminase Gene to Human Colon Carcinoma-Derived Tumors Induces Chemosensitivity to 5-Fluorocytosine

  1995cited by this paper
• Efficient hammerhead ribozyme-mediated cleavage of the structured hepatitis B virus encapsidation signal in vitro and in cell extracts, but not in intact cells.

  1995cited by this paper
• Receptor-mediated transfer of pSV2CAT DNA to a human hepatoblastoma cell line HepG2 using asialofetuin-labeled cationic liposomes.

  1995cited by this paper
• Gene transfer with synthetic cationic amphiphiles: prospects for gene therapy.

  1994cited by this paper

• Interpretation of the molecular mechanism and therapeutic potential of microRNA-155 in cardiovascular and cerebrovascular diseases (Review)

  2025cites this paper
• Polysaccharide conjugates surpass monosaccharide ligands in hepatospecific targeting - Synthesis and comparative in silico and in vitro assessment.

  2021cites this paper
• Polylipid Nanoparticle, a Novel Lipid-Based Vector for Liver Gene Transfer

  2013cites this paper
• Nano-vectors for effi cient liver specifi c gene transfer

  2008cites this paper
• Nano-vectors for efficient liver specific gene transfer

  2008cites this paper
• Disposition of 14C-β-carotene following delivery with autologous triacylglyceride-rich lipoproteins

  2007cites this paper
• Cyclic RGD Peptide-Labeled Liposomes for Targeting Drug Therapy of Hepatic Fibrosis in Rats

  2007influential citation
• Cyclic Arg-Gly-Asp Peptide-Labeled Liposomes for Targeting Drug Therapy of Hepatic Fibrosis in Rats

  2007cites this paper
• New therapies for familial hypercholesterolemia

  2006cites this paper
• HOURS OF RECEIPT TO : QUESTIONS ?

  2004cites this paper
• Liposome‐mediated extracellular superoxide dismutase gene delivery protects against acute liver injury in mice

  2004cites this paper
• Liposome-mediated extracellular superoxide dismutase gene delivery protects against acute liver injury in mice

  2004cites this paper
• Inhibition of hepatitis viral replication by siRNA

  2004cites this paper
• Targeted gene delivery into HepG2 cells using complexes containing DNA, cationized asialoorosomucoid and activated cationic liposomes.

  2003cites this paper
• Galactose-PEI-DNA complexes for targeted gene delivery: degree of substitution affects complex size and transfection efficiency.

  2003cites this paper
• Targeting hepatocytes for drug and gene delivery: emerging novel approaches and applications.

  2002cites this paper
• Novel Therapeutic Modalities for Hepatic Diseases

  2001cites this paper
• Toxicity of hepatotoxins: new insights into mechanisms and therapy.

  1999cites this paper
• NF-kappa B, liposomes and pathogenesis of hepatic injury and fibrosis.

  1999cites this paper
• Liver-Directed Gene Transfer in Non-Human Primates

  1997cites this paper